Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Big Pharma
A district court of appeal has paused MSN Pharmaceuticals’ launch | Result comes days after the Federal Circuit restored Novartis’ patent and overturned a decision in favour of MSN | Request is one in a flurry of filings between the pair over the heart-failure drug.   16 January 2025
Careers
Partner plus team of four patent attorneys and four paralegals join Munich office | Firm says the addition strengthens its position in German and international markets.   16 January 2025
Europe
New analysis examines funding gap for European startups and where to find investment | UK’s active VC market bucks trend in Europe where tech funding largely driven by public programmes.   16 January 2025
Careers
Ex-Corrs Chambers Westgarth pharma specialist joins firm’s growing litigation practice.   16 January 2025
Careers
IP specialist joins firm’s Bristol office | Transaction expert has advised AstraZeneca, Cancer Research Horizons, and other high-profile clients.   14 January 2025
Big Pharma
Federal circuit reverses district court’s ruling to revive combination patent | Novartis says patent has paediatric exclusivity expiring in July 2025.   14 January 2025
Europe
Company faces setback as EPO revokes patent for a C1-esterase inhibitor treatment | Patent aims at preventing antibody-mediated rejection in kidney transplant patients | Court cites insufficient clinical trial data.   9 January 2025
Careers
Skilled in microbiome, medical devices and next generation diagnostics, the new partner is skilled in creating IP strategies for startups, spinouts and SMEs.   9 January 2025
Americas
PTAB determines all but one of challenged claims unpatentable | Decision is latest instalment in clash over electrocardiogram technology | Apple bid to stop ‘AliveCor’s rampant infringement’ backfires.   9 January 2025
Americas
Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated secrets and breached contract | Companies in dispute process and manufacture medical products derived from human placental tissue.   7 January 2025